來源紀錄

Matching a cancer chart to trial eligibility

廠商

此語言的正文尚未翻譯，暫以英文顯示。

The source is Tempus’s company website, dated in this index as 1 April 2025, read as a vendor description of trial matching. Flatiron and Deep 6 AI are named as other companies that sell a version of the same job. The page is not an independent study of enrollment. No enrollment rate or days-saved figure is repeated, because those claims are vendor-specific and often omit how many suggestions a coordinator rejects.

來源日期: 2025年4月1日 · 年份 2025
證據標籤: 廠商報告
來源類型: 廠商

完整引用

Tempus

Tempus. Company website, dated in this index as 1 April 2025. https://www.tempus.com/ Vendor description of clinical data and trial services. Flatiron and Deep 6 AI are named only as other companies selling trial-matching tools. Not an enrollment study.

已公開的關鍵事實

The cited source is a vendor website, not a peer-reviewed enrollment study.
The tool reads structured fields and sometimes free text, and lists studies a patient might qualify for.
A research coordinator still checks every criterion against the chart.
A match list is not enrollment and not a treatment recommendation.
No enrollment-rate or speed figure is stated.

原始連結

在新分頁開啟發布者頁面。

返回本案例

供教育和市場掃描的目錄條目。不是醫療建議，也不是背書。